The department is the home for basic research in immunology and microbiology. Our mission is to advance the insights into the biology of microbes and the defense against microbial infections in order to develop future therapies for infectious, autoimmune, and malignant diseases.
Antibody blood tests look for the body’s immune response after someone has recovered from the disease. Dr. Janko Nikolich is one of the project’s leaders.
University of Arizona immunobiologist Michael Johnson is investigating why copper compounds are toxic to bacteria and describes how they could help scientists disrupt the path of the coronavirus.
Robbins announced in April his plans to resume in-person classes Aug. 24, bringing back 45,000 students and 15,000 faculty and staff for fall 2020.